R1 RCM Return on Equity

R1 RCM (RCM) currently reports a ROE of -2.18%. That is below the Healthcare sector average of 20.77%. Use the charts on this page to explore R1 RCM's ROE history and peer comparisons.

R1 RCM's ROE of -2.18% is lower than the Healthcare sector average of 20.77%. That is roughly 110.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but R1 RCM's current -2.18% should be judged against Healthcare norms (sector average: 20.77%) and against RCM's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -2.18%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 20.77%. From there, open related valuation or income-statement pages for R1 RCM, and consider following RCM for alerts when major investors trade the stock.

R1 RCM is classified in the Healthcare sector. On ROE, it currently shows -2.18% versus a sector average near 20.77%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RCM with unrelated industries.